Keytruda Regimen Misses Goal in Endometrial Cancer Trial
Adding Keytruda to chemotherapy with or without radiotherapy did not improve disease-free survival in newly diagnosed high-risk endometrial cancer.
Adding Keytruda to chemotherapy with or without radiotherapy did not improve disease-free survival in newly diagnosed high-risk endometrial cancer.
This weeks’ blog is by Helen Needham, Senior Lecturer and Practice lead for Learning disability nursing, Birmingham City University (helen.needham@bcu.ac.uk) I am currently conducting research…
Presurgical paclitaxel, Herceptin and Perjeta showed “incredible efficacy” in treatment of HER2-positive breast cancer.
Patients with HR-positive, HER2-low, and -ultralow metastatic breast cancer treated with trastuzumab deruxtecan obtained a PFS benefit vs chemotherapy.
RCN Congress is a fantastic opportunity for members to meet, learn, develop and share excellent nursing practice.
The next blog in our series which focuses on maternal inequalities comes from Nafiza Anwar, one of the founders of the Association of South Asian…
A general practice nurse has told how a leadership programme has supported her to find her ‘voice’ and ‘open doors.’
Researchers found telehealth care to deliver comparable quality-of-life benefits versus in-person visits among patients with advanced non-small cell lung cancer.
For the first time in decades, a new regimen — consolidation Imfinzi after chemoradiation — improved outcomes in patients with limited-stage small cell lung cancer.
Researchers found that adding retroperitoneal lymphadenectomy to cytoreductive surgery did not improve survival among patients with advanced ovarian cancer.
Tagrisso following chemoradiotherapy improved progression-free survival compared with placebo in stage 3 EGFR-mutated non–small cell lung cancer.